Using drugs that inhibit enzymes called CDK4/6 and CDK2 extends the G1 phase of the cell cycle and helps to slow the growth of drug-resistant breast cancer.

There is buzz around Graphite One Incorporated's (G1) request to increase its debt financing for new projects, which includes ...

Given this engineered separation, the Dyson Wash G1 is incredibly easy – and more importantly hygienic – to clean. You simply ...

As of Thursday, December 18, Pyxis Oncology, Inc.’s PYXS share price has dipped by 53.39%, which has investors questioning if ...

Mirum Pharmaceuticals is paying $620 million in cash and stock to buy Bluejay Therapeutics and its phase 3-stage hepatitis drug. At the heart of the deal is brelovitug, an immunoglobulin G1 monoclonal ...

Activity on the sun is not constant; it varies along a cycle of about 11 years. The peak of this solar cycle — called solar ...

T1 Energy Inc. has begun construction on its G2_Austin solar cell fab in Milam County, Texas, a US$400–US$425 million project expected to deliver 2.1GW of high-efficiency TOPCon solar cell capacity in ...

A collaboration between the University of Edinburgh and Imperial College London has used a dual-view oblique plane ...

Mirum Pharmaceuticals acquires Bluejay Therapeutics to expand its pipeline into liver diseases. Read more here.

Abcuro, Inc., a late-stage clinical biotechnology company developing potentially first-in-class immunotherapies designed to ...

T1 Energy has started construction on the 2.1GW first phase of its TOPCon cell manufacturing facility in Texas.

GW Phase One Expected to Substantially Increase Domestic Silicon Cell SupplyAUSTIN, Texas and NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) -- T1 Energy Inc. (NYSE: TE) (“T1,” “T1 Energy,” or the “Company” ...